Reason Wilken

2.4k total citations · 1 hit paper
26 papers, 1.7k citations indexed

About

Reason Wilken is a scholar working on Dermatology, Oncology and Epidemiology. According to data from OpenAlex, Reason Wilken has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Dermatology, 8 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Reason Wilken's work include Autoimmune Bullous Skin Diseases (4 papers), Immunotherapy and Immune Responses (4 papers) and Nonmelanoma Skin Cancer Studies (4 papers). Reason Wilken is often cited by papers focused on Autoimmune Bullous Skin Diseases (4 papers), Immunotherapy and Immune Responses (4 papers) and Nonmelanoma Skin Cancer Studies (4 papers). Reason Wilken collaborates with scholars based in United States. Reason Wilken's co-authors include Eri S. Srivatsan, Mysore S. Veena, Marilene B. Wang, Emanual Maverakis, S. P. Raychaudhuri, Forum Patel, Michiko Shimoda, Carlito B. Lebrilla, Kyoungmi Kim and L. Renee Ruhaak and has published in prestigious journals such as Journal of Biological Chemistry, Frontiers in Immunology and Molecular Cancer.

In The Last Decade

Reason Wilken

26 papers receiving 1.7k citations

Hit Papers

Curcumin: A review of anti-cancer properties and therapeu... 2011 2026 2016 2021 2011 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reason Wilken United States 11 720 456 331 239 153 26 1.7k
Jing Qi China 28 829 1.2× 257 0.6× 354 1.1× 226 0.9× 101 0.7× 66 2.6k
Vibhudutta Awasthi United States 26 1.0k 1.4× 234 0.5× 207 0.6× 204 0.9× 146 1.0× 100 2.2k
Ana Beloqui Belgium 29 1.0k 1.4× 238 0.5× 180 0.5× 152 0.6× 168 1.1× 58 3.0k
Parama Dey India 29 1.2k 1.7× 179 0.4× 239 0.7× 491 2.1× 124 0.8× 50 2.2k
Xiaolin Li China 31 1.0k 1.5× 191 0.4× 141 0.4× 302 1.3× 210 1.4× 96 2.7k
Vamshi Krishna Rapalli India 28 429 0.6× 151 0.3× 274 0.8× 49 0.2× 61 0.4× 34 2.0k
Young Wook Choi South Korea 33 894 1.2× 104 0.2× 129 0.4× 178 0.7× 99 0.6× 133 3.1k
Mohsen Mohammadi Iran 21 1.1k 1.6× 268 0.6× 162 0.5× 166 0.7× 179 1.2× 74 2.1k
Hibah M. Aldawsari Saudi Arabia 28 864 1.2× 137 0.3× 251 0.8× 242 1.0× 71 0.5× 84 2.4k
Saugata Hazra India 27 956 1.3× 175 0.4× 153 0.5× 176 0.7× 173 1.1× 75 1.8k

Countries citing papers authored by Reason Wilken

Since Specialization
Citations

This map shows the geographic impact of Reason Wilken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reason Wilken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reason Wilken more than expected).

Fields of papers citing papers by Reason Wilken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reason Wilken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reason Wilken. The network helps show where Reason Wilken may publish in the future.

Co-authorship network of co-authors of Reason Wilken

This figure shows the co-authorship network connecting the top 25 collaborators of Reason Wilken. A scholar is included among the top collaborators of Reason Wilken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reason Wilken. Reason Wilken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Criscito, Maressa C., Reason Wilken, Mary L. Stevenson, & John A. Carucci. (2022). Deliberate practice-based surgical curriculum leads to enhanced technical proficiency among dermatology residents. Archives of Dermatological Research. 314(9). 905–908. 1 indexed citations
2.
Wilken, Reason, John A. Carucci, & Mary L. Stevenson. (2021). Skin Cancers and Lung Transplant. Seminars in Respiratory and Critical Care Medicine. 42(3). 483–496. 1 indexed citations
3.
Doudican, Nicole, et al.. (2020). Current concepts and approaches to merkel cell carcinoma. Archives of Dermatological Research. 313(3). 129–138. 8 indexed citations
4.
Wilken, Reason, Maressa C. Criscito, Anna C. Pavlick, Mary L. Stevenson, & John A. Carucci. (2020). Current Research in Melanoma and Aggressive Nonmelanoma Skin Cancer. Facial Plastic Surgery. 36(2). 200–210. 8 indexed citations
5.
Nguyen, Mimi, et al.. (2020). A patient with anti-NXP2-positive dermatomyositis and syphilis. Dermatology Online Journal. 26(2). 1 indexed citations
6.
Le, Stephanie T., Jenny Wang, Forum Patel, et al.. (2019). End stage scurvy in the developed world: A diagnostic conundrum but not to be mistaken for pyoderma gangrenosum. International Wound Journal. 16(4). 1024–1028. 5 indexed citations
7.
Wang, Elizabeth A., Andrea Steel, Guillaume Luxardi, et al.. (2018). Classic Ulcerative Pyoderma Gangrenosum Is a T Cell-Mediated Disease Targeting Follicular Adnexal Structures: A Hypothesis Based on Molecular and Clinicopathologic Studies. Frontiers in Immunology. 8. 1980–1980. 52 indexed citations
8.
Davis, Michael J., Reason Wilken, Maxwell A. Fung, & Danielle Tartar. (2018). Debilitating erosive lichenoid interface dermatitis from checkpoint inhibitor therapy. Dermatology Online Journal. 24(4). 2 indexed citations
9.
Raychaudhuri, S. P., et al.. (2016). Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies. Journal of Autoimmunity. 76. 21–37. 84 indexed citations
10.
Wilken, Reason, Forum Patel, J. Bruce German, et al.. (2016). Dietary supplementation with Bifidobacterium longum subsp. infantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial. Trials. 17(1). 340–340. 7 indexed citations
11.
Wilken, Reason, et al.. (2016). The Role of Professional Identity Formation in Balancing Residency Service Versus Educational Needs. Journal of Graduate Medical Education. 8(2). 154–155. 5 indexed citations
12.
Wilken, Reason, et al.. (2015). Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial. Trials. 16(1). 374–374. 4 indexed citations
13.
Maverakis, Emanual, et al.. (2015). Pathophysiology of autoimmune bullous diseases: Nature versus nurture. Indian Journal of Dermatology. 62(3). 262–262. 20 indexed citations
14.
Maverakis, Emanual, Kyoungmi Kim, Michiko Shimoda, et al.. (2015). Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: A critical review. Journal of Autoimmunity. 57. 1–13. 344 indexed citations
15.
Shi, Vivian Y., Khiem A. Tran, Forum Patel, et al.. (2015). 100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: Results of a case series. Journal of the American Academy of Dermatology. 73(4). 645–654. 35 indexed citations
16.
Maverakis, Emanual, Lynn A. Cornelius, Grace Bowen, et al.. (2014). Metastatic Melanoma – A Review of Current and Future Treatment Options. Acta Dermato Venereologica. 95(5). 516–524. 170 indexed citations
17.
Veena, Mysore S., Reason Wilken, Junying Zheng, et al.. (2014). p16 Protein and Gigaxonin Are Associated with the Ubiquitination of NFκB in Cisplatin-induced Senescence of Cancer Cells. Journal of Biological Chemistry. 289(50). 34921–34937. 24 indexed citations
18.
Patel, Forum, Reason Wilken, Barbara Burrall, et al.. (2014). Detailed protocol for administration of intralesional IL-2 for the treatment of Stage IIIc and IV M1a metastatic melanoma based on current NCCN guidelines. Dermatology Online Journal. 20(11). 2 indexed citations
19.
Wilken, Reason, et al.. (2012). Measurable Progress in Female Authorship in Otolaryngology. Otolaryngology. 147(1). 40–43. 54 indexed citations
20.
Wilken, Reason, Mysore S. Veena, Marilene B. Wang, & Eri S. Srivatsan. (2011). Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Molecular Cancer. 10(1). 12–12. 823 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026